why so quiet?, page-7

>>I'm surprised there has been no comment yet about the quarterly update. OK, so it was fairly brief, but there were a couple of good positives in it.

For a start, the company expects to have sufficient funding to meet operating costs until August next year - not taking into account any royalties received in the mean time. So capital raisings are off the agenda for a fair while at least.

I also like the comments regarding other companies that have finished their own laboratory testing and are now discussing commercial aspects. This I take to mean contract negotiations. Surely, if things have progressed as positively as the announcement implies, this means further production/supply agreements will not be too far away.<<

Yes I was surprised that the SP did not go up. In the current climate of volitility the more risk adverse stocks are being hammered I guess. ADO stands its ground...

Knowing the details of the ADO story and the potential market changing Biotech they are now selling. I exited some resource stocks to load up in ADO. To me, below 5c is a safe bet. Plus I need to convert my million Oppies before Sep this year. Which i will do... Most will I assume unless they decide to sell on market and buy heads instead if bullish in the company.

Not that many Oppies left, you may get a small premium for your Oppies on market, yet not so liquid now with so few left on offer. I presume all us LT Oppie holders will convert. As it only 1.5c, then the company is cashed up to continue till 2012.

Great position to be in- great biotech on market and selling now, others very interested to cut a deal, possible market changing biotech, and cashed up even if royalities come slower than expected.

It a winner if they get 10 mil in royalities over the next year which is very possible- IMO. All holders will be winners in this sinerio in its first year of selling MIXnGO plus others. Others on the way...

Good safe haven in my mind in volitile times at these levels. IMO. DYOR.